These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31291281)

  • 21. Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda.
    Izudi J; Alioni S; Kerukadho E; Ndungutse D
    BMC Infect Dis; 2016 Oct; 16(1):614. PubMed ID: 27793124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia.
    Ebissa G; Deyessa N; Biadgilign S
    AIDS Care; 2015; 27(6):723-30. PubMed ID: 25599414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-state Markov model for time to treatment changes for HIV/AIDS patients: a retrospective cohort national datasets, Ethiopia.
    Kumsa TH; Mulu A; Beyene J; Asfaw ZG
    BMC Infect Dis; 2024 Jun; 24(1):627. PubMed ID: 38914968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in Ethiopia.
    Gleason RL; Caulk AW; Seifu D; Rosebush JC; Shapiro AM; Schwartz MH; Eckard AR; Amogne W; Abebe W
    J Biomech; 2016 Sep; 49(13):2584-2592. PubMed ID: 27270208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy and tolerance of efavirenz- and nevirapine-containing regimens in adult HIV type 1 Senegalese patients.
    de Beaudrap P; Etard JF; Guèye FN; Guèye M; Landman R; Girard PM; Sow PS; Ndoye I; Delaporte E;
    AIDS Res Hum Retroviruses; 2008 Jun; 24(6):753-60. PubMed ID: 18507521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4 cell count trends after commencement of antiretroviral therapy among HIV-infected patients in Tigray, Northern Ethiopia: a retrospective cross-sectional study.
    Asfaw A; Ali D; Eticha T; Alemayehu A; Alemayehu M; Kindeya F
    PLoS One; 2015; 10(3):e0122583. PubMed ID: 25816222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors for CD4 cell count and hemoglobin level with survival time to default for HIV positive adults under ART treatment at University of Gondar Comprehensive and Specialized Hospital, Ethiopia.
    Muhie NS; Tegegne AS
    BMC Res Notes; 2023 Dec; 16(1):357. PubMed ID: 38042846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naïve patients: a cohort study.
    Keiser P; Nassar N; White C; Koen G; Moreno S
    HIV Clin Trials; 2002; 3(4):296-303. PubMed ID: 12187503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rate of initial highly active anti-retroviral therapy regimen change and its predictors among adult HIV patients at University of Gondar Referral Hospital, Northwest Ethiopia: a retrospective follow up study.
    Anlay DZ; Alemayehu ZA; Dachew BA
    AIDS Res Ther; 2016; 13():10. PubMed ID: 26889204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India.
    Rajasekaran S; Jeyaseelan L; Raja K; Vijila S; Krithigaipriya KA; Kuralmozhi R
    J Postgrad Med; 2009; 55(4):261-6. PubMed ID: 20083872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
    Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
    J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of change in CD4 lymphocyte count and weight among HIV infected patients on anti-retroviral treatment in Ethiopia: a retrospective longitudinal study.
    Reda AA; Biadgilign S; Deribew A; Gebre B; Deribe K
    PLoS One; 2013; 8(4):e58595. PubMed ID: 23573191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 tropism and CD4 T lymphocyte recovery in a prospective cohort of patients initiating HAART in Ribeirão Preto, Brazil.
    Lanca AM; Collares JK; Ferreira JL; Lima DM; Brigido LF; Rodrigues R; Fonseca BA
    Mem Inst Oswaldo Cruz; 2012 Feb; 107(1):96-101. PubMed ID: 22310542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
    Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
    Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in nutritional, functional and immunological status of HIV-infected adults with antiretroviral therapy.
    Tafese Z; Berhan Y; Abebe H
    Ethiop Med J; 2012 Jan; 50(1):75-87. PubMed ID: 22519164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.
    Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):756-76. PubMed ID: 19500017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quasi-Poisson versus negative binomial regression models in identifying factors affecting initial CD4 cell count change due to antiretroviral therapy administered to HIV-positive adults in North-West Ethiopia (Amhara region).
    Seyoum A; Ndlovu P; Zewotir T
    AIDS Res Ther; 2016; 13():36. PubMed ID: 27843481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.
    Manosuthi W; Mankatitham W; Lueangniyomkul A; Chimsuntorn S; Sungkanuparph S
    HIV Med; 2008 May; 9(5):294-9. PubMed ID: 18400076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting CD4 count changes among patients on antiretroviral treatment: Application of data mining techniques.
    Kebede M; Zegeye DT; Zeleke BM
    Comput Methods Programs Biomed; 2017 Dec; 152():149-157. PubMed ID: 29054255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.